Industry News

KilgourMD Releases Phase II Clinical Trial Data on Menopausal Hair Loss

Independent, four-month trial evaluating prevention and treatment serums.

Author Image

By: Christine Esposito

Editor-in-Chief

KilgourMD has released results from an independent, four-month phase II clinical trial evaluating the KilgourMD System, composed of prevention and treatment serums, in 43 menopausal-aged women experiencing androgenetic alopecia. Overall, the study found clinically meaningful regrowth in record time, alongside validated reductions in hair shedding. By day 120, results showed that 53% of participants achieved at least a half-grade improvement on the modified Female Ludwig scale, a threshold ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters